Treatment with recombinant growth hormone is associated with modest improvement in CD4 lymphocyte reconstitution in HIV-infected persons on antiretroviral therapy: Results of ACTG A5174

AIDS Research and Human Retroviruses

Volumn 26, Issue 4, 2010, Pages 425-432

  Smith, Kimberly ^a   Zheng, Lu ^b   Bosch, Ronald ^b   Tenorio, Allan ^a   Napolitano, Laura ^c   Saag, Michael ^d   Connick, Elizabeth ^e   Gross, Barry ^f   Francis, Isaac ^f   Valdez, Hernan ^g   Muurahainen, Norma ^h   Stocker, Vicky ⁱ   Pollard, Richard ^j  

^a RUSH UNIVERSITY   (United States)

^b CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d University of Alabama at Birmingham   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^g PFIZER INC   (United States)

^h EMD SERONO INC   (United States)

ⁱ SOCIAL AND SCIENTIFIC SYSTEMS INC   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; KEYHOLE LIMPET HEMOCYANIN; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C;

ADOLESCENT; ADULT; ANTIGEN FUNCTION; ARTICLE; CARPAL TUNNEL SYNDROME; CD4 LYMPHOCYTE COUNT; CD4 LYMPHOCYTE PERCENTAGE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; DRUG WITHDRAWAL; EDEMA; FEMALE; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; LEUKOCYTE METABOLISM; LOW DRUG DOSE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE MIGRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUSCLE STIFFNESS; ORGAN SIZE; PAIN; PARESTHESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; THYMUS; TREATMENT DURATION; VACCINATION;

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; CD4-POSITIVE T-LYMPHOCYTES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HIV INFECTIONS; HIV-1; HUMAN GROWTH HORMONE; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PILOT PROJECTS; RECOMBINANT PROTEINS; T-LYMPHOCYTE SUBSETS; THYMUS GLAND; TREATMENT OUTCOME;

EID: 77951874503     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2009.0052     Document Type: Article

References (30)

1. Ho DD, Neumann AU, Perelson AS, et al.: Rapid turnover of plasma virions and CD4 lymphocytes in HIV infection. Nature 1995;373:123-126.
2. Wolters KC, Shuitemaker H, and Miedema F: Rapid CD4 T-cell turnover in HIV-1 infection: A paradigm revisited. Immunol Today 1998;19:44-48.
3. Conners M, Kovacs JA, Krevat S, et al.: HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T cell repertoire that are not immediately restored by antiviral or immune based therapies. Nat Med 1997;3: 533-540.
4. Lederman M, Connick E, Landay A, et al.: Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: Results of AIDS Clinical Trials Groups Protocol. J Infect Dis 1998;178:70-78.
5. Autran B, Carcelain G, Li TS, et al.: Positive effects of combined antiretroviral therapy on CD4+ T-cell homeostasis and function in advanced HIV disease. Science 1997;277: 112-116.
6. Connick E, Lederman M, Kotzin B, et al.: Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response. J Infect Dis 2000;181:358-363.
7. Valdez H, Connick E, Smith KY, et al.: Limited immune restoration after 3 years' suppression after HIV-1 replication in patients with moderately advanced disease. AIDS 2002; 16:1850-1866.
8. Komanduri KV, Feinberg J, Hutchins RK, et al.: Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis. J Infect Dis 2001;183(8):1285-1289.
9. Douek DC, McFarland RD, Keiser PH, et al.: Changes in thymic function with age and during the treatment of HIV infection. Nature 1998;396:690-694.
10. Pakker NG, Notermanns DW, de Boer RJ, et al.: Biphasic kinetics of peripheral blood cells after triple combination therapy in HIV infection: A composite of redistribution and proliferation. Nat Med 1998;4:208-214.
11. Murphy WJ, Durum SK, Anver MR, et al.: Immunologic and hematologic effects of neuroendocrine hormones. Studies on DW=J dwarf mice. J Immunol 1992;148:3799-3805.
12. Binz, K, Joller P, Froesch P, et al.: Repopulation of atrophied thymus in diabetic rats by insulin-like growth factor 1. Proc Natl Acad Sci USA 1990;87:3690-3694.
13. Geffner ME, Bersh N, Lippe BM, et al.: Growth hormone mediates the growth of T-lymphoblast cell lines via locally generated insulin-like growth factor 1. J Clin Endocrinol Metab 1990;71:464-469.
14. Clark R, Strasser J, McCabe S, et al.: Insulin-like growth factor type 1 stimulation of lymphopoiesis. J Clin Invest 1993;92:540-548.
15. Mellado M, Llorente M, Rodriguez-Frade M, et al.: HIV-1 envelope protein gp 120 triggers a Th2 response in mice that shifts to Th1 in the presence of human growth hormone. Vaccine 1998;16:1111-1115.
16. Napolitano LA, Lo JC, Gotway MB, et al.: Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormone. AIDS 2002;16:1103-1111.
17. AIDS Clinical Trials Group Immunology Laboratory Committee Consensus: Methodologies. Bethesda, MD: NIH, 2000; http:==aactg.s-3.com.
18. Al-Harthi L, Marchetti G, Steffens CM, et al.: Detection of T cell receptor circles (TRECs) as biomarkers for de novo T cell synthesis using a quantitative polymerase chain reactionenzyme linked immunosorbent assay (PCR-ELISA). J Immunol Methods 2000;237:187.
19. McCune JM, Loftus R, Schmidt DK, et al.: High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection. J Clin Invest 1998;101:2301-2308.
20. Smith KY, Valdez H, Landay R, et al.: Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy. J Infect Dis 2000;181(1): 141-147.
21. Kimmig S, Przybylski GK, Schmidt CA, et al.: Two subsets of naïve T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J Exp Med 2002;195:789-794.
22. Napolitano L, Schmidt D, Gotway MB, et al.: Growth hormone enhances thymic function in HIV-1 infected adults. J Clin Invest 2008;118(3):1085-1098.
23. Franco JM, Rubio A, Martínez-Moya M, et al.: T-cell repopulation and thymic volume in HIV-1-infected adult patients after highly active antiretroviral therapy. Blood 2002; 99(10):3702-3706. (Pubitemid 34534541)
24. Harris JM, Hazenberg MD, Poulin JF, et al.: Multiparameter evaluation of human thymic function: Interpretations and caveats. Clin Immunol 2005;115(2):138-146.
25. Kolte L, Dreves AM, Ersbøll AK, et al.: Association between larger thymic size and higher thymic output in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy. J Infect Dis 2002;185(11):1578-1585. Epub May 17, 2002.
26. Markert ML, Alvarez-McLeod AP, Sempowski GD, et al.: Thymopoiesis in HIV-infected adults after highly active antiretroviral therapy. AIDS Res Hum Retroviruses 2001; 17(17):1635-1643.
27. de Mello-Coelho V, Gagnerault M-C, Souberbielle J-C, et al.: Growth hormone and its receptor are expressed in human thymic cells. Endocrinology 1998;139:3837-3842.
28. Yu-Waye Chu, Sarfraz A, Memon SO, Sharrow, et al.: Exogenous IL-7 increases recent thymic emigrants in peripheral lymphoid tissue without enhanced thymic function. Blood 2004;104:1110-1119.
29. Antonio Pires, Jeffery Pido-Lopez, Graeme Moyle, et al.: Enhanced T-cell maturation, differentiation and function in HIV-1 infected individuals after growth hormone and highly active antiretroviral therapy. Antiviral Ther 2004;9:67-75.
30. Valdez H, Mitsuyasu R, Landay A, et al.: Interleukin-2 increases CD4+ lymphocyte numbers but does not enhance responses to immunization: Results of A5046s. J Infect Dis 2003;187(2):320-325.